SC Filed 2023-06-02 Event — SEC 0000902664-23-003402 →

Caligan Partners LP → EXELIXIS, INC. EXEL

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 11.00

27,263,165 shares short · +3.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $37.52M

Point72 Asset Mgmt

Other 13D/G Filings on EXELIXIS, INC.

Filed	Form	Filer	Stake	Shares
2026-01-05	SCHEDULE	Farallon Capital Partners, L.P.	5.90%	15,709,500	view →
2025-05-20	SCHEDULE	Farallon Capital Partners, L.P.	6.80%	18,635,500	view →
2025-03-05	SCHEDULE	Farallon Capital Partners, L.P.	8.40%	23,439,500	view →
2018-01-04	SC	Meditor Group Ltd	—	—	view →

Other Filings by Caligan Partners LP

Filed	Form	Issuer	Stake	Shares
2026-01-27	SCHEDULE	Anika Therapeutics, Inc. ANIK	9.95%	1,435,130	view →
2024-05-30	SC	Anika Therapeutics, Inc. ANIK	—	—	view →
2024-01-08	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2023-07-03	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2022-08-05	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2021-12-07	SC	Liquidia Corp LQDA	—	—	view →
2020-11-16	SC	AMAG PHARMACEUTICALS, INC.	—	—	view →
2019-10-10	SC	AMAG PHARMACEUTICALS, INC.	—	—	view →
2019-09-30	SC	Knowles Corp KN	—	—	view →
2019-09-04	SC	AMAG PHARMACEUTICALS, INC.	—	—	view →
2019-05-09	SC	Knowles Corp KN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →